Virus News and Research

Latest Virus News and Research

Study explores adverse effects of SARS-CoV-2-induced antibody responses

The authors of a research paper published in the journal Frontiers in Immunology used Sandwich ELISA tests to determine the distribution of IgG sub-classes and complement activation levels in plasma from convalescent individuals.

25 Nov 2021

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field.

25 Nov 2021

Using metal nanoparticles to fight SARS-CoV-2

A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.

25 Nov 2021

What may the future hold in terms of SARS-CoV-2 variants?

Researchers fit data on SARS-CoV-2 variants by exploiting a function that depends on the global number of infected cases since the start of the pandemic.

25 Nov 2021

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

Researchers measured anti-RBD IgG and virus neutralization before and after vaccination with boosters.

25 Nov 2021

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Some of the UK's leading health charities including the British Heart Foundation, Diabetes UK and Cancer Research UK are joining forces with the government and the NHS to encourage vulnerable people to get their COVID-19 vaccines.

25 Nov 2021

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

A new statistical analysis supports beliefs that COVID-19 became more lethal in the U.K. in late 2020, while also suggesting that multiple factors - not just the alpha variant of the virus that causes COVID-19 - were to blame.

25 Nov 2021

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that after receiving cancer treatment, the oral administration of direct-acting antivirals (DAA) reduces the risk of tumor progression following recurrence of the liver disease.

25 Nov 2021

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

In a study published in The Lancet Infectious Diseases, researchers investigated the effectiveness of the BBV152 vaccine among employees of the All India Institute of Medical Sciences.

25 Nov 2021

SARS-CoV-2 Delta variant mutation sites

A new review article dissected the sites of mutation in the RBD of the Delta variant and other variants of concern and variants of alert and interest.

25 Nov 2021

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

A new study published on the medRxiv* preprint server employed in-silico techniques, combining genomic and epidemiological data, to determine possible Delta-variant transmission events between vaccinated healthcare workers (HCWs) in Indian hospitals.

25 Nov 2021

Maternal-fetal interface yields intriguing clues to how it battles SARS-CoV-2

Scientists have hypothesized that the number of immune cells and the amount of cytokines produced in response to SARS-CoV-2 infection in pregnant women change in accordance with the timing of maternal infection in pregnancy. This study is available on the bioRxiv* preprint server.

24 Nov 2021

Virus News and Research

Latest Virus News and Research

Study explores adverse effects of SARS-CoV-2-induced antibody responses

Researchers reveal possible role for anti-idiotype antibodies in long-term effects of COVID-19

Using metal nanoparticles to fight SARS-CoV-2

What may the future hold in terms of SARS-CoV-2 variants?

COVID-19 vaccine boosters to prevent breakthrough SARS-CoV-2 infections in healthy adults

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

COVID-19 became more lethal in the U.K. in late 2020, statistical analysis suggests

Direct-acting antivirals for HCV-related hepatocellular carcinoma reduces the risk of tumor progression

Study demonstrates effectiveness of two doses of BBV152 vaccine against COVID-19

SARS-CoV-2 Delta variant mutation sites

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

Maternal-fetal interface yields intriguing clues to how it battles SARS-CoV-2

Can COVID-19 affect erectile function?

Combination of iota-carrageenan and xylitol as a potential nasal spray for COVID

Acute SARS-CoV-2 infection during pregnancy associated with placental ACE2 shedding

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

SARS-CoV-2 reinfection and the natural immune response

Scientists now close to eliminating mother-baby HIV transmission, says leading researcher

Can dexamethasone reduce prolonged COVID-19 symptoms?

Trust increases adherence to non-pharmaceutical interventions that curb COVID-19

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in